跳至主要内容
临床试验/DRKS00003065
DRKS00003065已完成不适用

The Importance of Glutamine Concentration in Plasma for Cancer Related Fatigue - Fatigue Trial

Fresenius Kabi Deutschland GmbH0 个研究点目标入组 100 人开始时间: 2011年4月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients with solid tumor (e.g. colorectal carcinoma, stomach cancer, breast cancer, bronchial carcinoma, tumor in ENT region) and with causally determinded systemic therapy (radio- and/or chemo therapy).
  • Concentration of hemoglobin 9 g/dl or above
  • Patients without receiving blood transfusion or erythrocyte concentrate within last 4 weeks

排除标准

  • - under 18 years
  • - not capable of understanding German language
  • - with psychological disorder
  • - with parenteral nutrition
  • - with active infection, requiring treatment
  • - with hematologic tumor (leukaemia)
  • - with glutamine treatment during the last 4 weeks
  • - with previous erythropoietin treatment
  • - Pregnant or breast feeding women

研究者

相似试验